Stock Events

Stock Events

Larimar Therapeutics (ZA71.F) Q4 2024 Earnings

30OctConfirmed

Q4 2023

Q2 2024

Q3 2024

Q4 2024

-0.35

-0.3

-0.26

-0.22

Details

Expected EPS

-0.34506847008

Actual EPS

-0.2210112

Surprise EPS

0.12

Surprise Percent

+35.95%

Description

Larimar Therapeutics (ZA71.F) has reported earnings of -0.2210112 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.